Galvus (Vildagliptin): Galvus is in a new class of drugs called DPP-4 Inhibitors, which are used to treat Type 2 diabetes. Galvus can be used in combination with other diabetic drug medications and has been approved for use in Europe. Taking medication is not a guarantee that blood sugar levels will be kept at acceptable levels; diabetics need to test their blood sugar with either a blood glucose meter or blood sugar monitor.

Galvus (vildagliptin) - DPP-IV Inhibitor / Oral Antidiabetic Agent
Galvus (vildagliptin) - DPP-IV Inhibitor / Oral Antidiabetic Agent drugdevelopment-technology.com Key Data Drug (brand / generic)Galvus (vildagliptin)Company / licenseeNovartisTherapy classDPP
http://www.drugdevelopment-technology.com/projects...
Galvus(R) Better Tolerated By Type 2 Diabetes Patients With No Weight Gain, A Favorable Cardiovascular Profile And Equal Efficacy Compared To TZDs
Galvus(R) Better Tolerated By Type 2 Diabetes Patients With No Weight Gain, A Favorable Cardiovascular Profile And Equal Efficacy Compared To TZDs 10 Sep 2008 MedicalNewsToday.com New data show
Galvus(R) Better Tolerated By Type 2 Diabetes Patients With No Weight Gain, A Fa...
Galvus(R), A New Treatment For Patients With Type 2 Diabetes, Receives European Approval For Label Update Paving The Way For EU Launches
Galvus(R), A New Treatment For Patients With Type 2 Diabetes, Receives European Approval For Label Update Paving The Way For EU Launches Article Date: 04 Feb 2008 Medicalnewstoday.com European
Galvus(R), A New Treatment For Patients With Type 2 Diabetes, Receives European ...